KUMAMOTO UNIVERSITY IMAGE: LOW DOSE METFORMIN WAS FOUND TO HAVE A NEPHROPROTECTIVE EFFECT SIMILAR TO LOSARTAN. CREDIT: PROFESSOR HIROFUMI KAI Researchers from Kumamoto University(Japan) have found that the anti-diabetic drug metformin significantly prolongs the survival of mice in a model that simulates the pathology of non-diabetic chronic kidney disease (ND-CKD) by ameliorating pathological conditions like reduced...
By Ana Sandoiu Fact checked by Paula Field New research finds that the diabetes drug metformin changes stem cancer cells in a way that makes them easier to target with a new form of treatment. The findings could help treat triple-negative breast cancer, which is particularly aggressive. Triple-negative breast cancer is an aggressive form of breast cancer...
Canadian and British researchers have discovered how the frontline Type 2 diabetes drugmetformin may work to help cells better take up and use glucose. Their study, published today in the prestigious journal Cell, may also explain other potential beneficial effects of metformin for prevention of a variety of chronic diseases, including cancers. To show that metformin appeared to make the cells act as...
